Navigation Links
Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2009 Financial Results
Date:3/3/2010

Jazz Pharmaceuticals is increasing its full year 2010 guidance for product sales and net income per diluted share, reflecting continued growth in XYREM and LUVOX CR net sales.  Jazz Pharmaceuticals is also reiterating the 2010 guidance on expenses issued in January 2010.

    
    
                                                  2010 Guidance
                                                  ------------- 
    
    - Total product sales                      $148 – $158 million 
         -- Xyrem                              $124 – $130 million
         -- Luvox CR                            $24 –  $28 million
    - Gross margin                             greater than 90%
    - SG&A expenses                             $65 –   $75 million
    - R&D expenses                              $25 –   $35 million
    - GAAP net income per diluted share       $0.27 –  $0.41
    - Adjusted net income per diluted share   $0.80 –  $0.95(1)
    
    (1) A reconciliation to GAAP net income per diluted share is available 
        in a table at the end of this press release
    
    
    

"2009 was a pivotal year for our business," said Bruce Cozadd, Chairman and Chief Executive Officer of Jazz Pharmaceuticals.  "We achieved profitability in the fourth quarter of 2009 and we expect continued profitability in 2010 driven by sales growth and prudent expense management.  We plan to use cash flows from operations in 2010 to amortize a portion of ou
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
3. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
4. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
5. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
6. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
7. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
8. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
9. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
10. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
11. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... RALEIGH, N.C. , Dec. 23, 2014 /PRNewswire/ ... (NASDAQ: ENDP ) (TSX: ENL), and BioDelivery ... today that they have submitted a New Drug Application ... Food and Drug Administration (FDA).  Buprenorphine HCl Buccal Film ... enough to require daily, around-the-clock, long-term opioid treatment and ...
(Date:12/22/2014)... , Dec. 22, 2014 NxStage Medical, ... of innovative dialysis products, announced today that the ... its System One™ to perform hemodialysis overnight while ... home nocturnal hemodialysis. NxStage,s® System One is the ... FDA for this indication. Home ...
(Date:12/22/2014)... , Dec. 22, 2014   TRU-D SmartUVC ... no-touch UV disinfection robot, announced today that the General ... contract through November 2019.   This newly ... engage all levels of government purchasers, including Department of ... well as Homeland Security contacts purchasing solutions for the ...
Breaking Medicine Technology:Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 5NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3TRU-D SmartUVC LLC Awarded General Services Administration Contract to Expand Government Customer Base 2
... acute lymphoblastic,leukemia combined with molecular science could help ... MEMPHIS, Tenn., March 20 The dramatic,increase that ... with acute,lymphoblastic leukemia (ALL) will be difficult to ... to an article,by St. Jude Children,s Research Hospital ...
... 20 NanoBio Corporation,announced today that it has ... phase 2 study of NB-002, a topical lotion ... the results clearly,justify completing the study, according to ... to grow out a clear nail after,successfully treating ...
Cached Medicine Technology:Molecular Science Could Further Improve Leukemia Survival, Say St. Jude Researchers 2NanoBio Corporation Completes Interim Analysis of Phase 2 Clinical Trial in Onychomycosis 2
(Date:12/25/2014)... 2014 The report “TS-1 (Colorectal Cancer) ... the current treatment landscape, unmet needs, current pipeline and ... an anti-cancer drug which is typically used for treating ... used for treating gastric cancer and pancreatic cancer. TS-1 ... drug was first approved in 1999 in Japan for ...
(Date:12/25/2014)... Recently, Dylan Queen, a famous online company ... collection of discounted prom dresses, most of which are ... of the company, the promotion is valid until Jan. ... expand the UK market. , The prom dresses in ... and styles: A-line strapless, empire strapless chiffon, one shoulder, ...
(Date:12/25/2014)... Helen Harris’ RP (Retinitis Pigmentosa) International founder ... an 8 year battle with breast cancer. , ... her home in Woodland Hills California after an 8 ... , As the founder and volunteer President of ... championed many of today's greatest breakthroughs in restoring and ...
(Date:12/25/2014)... 25, 2014 (HealthDay News) -- The risk of burns ... so you need to be extra cautious, an expert ... see a significant increase in patients coming in with ... Suffolk County Volunteer Firefighters Burn Center of Stony Brook ... be full of joy, but if not careful, could ...
(Date:12/25/2014)... AngelWeddingDress.com tries its best to translate the experience of ... has introduced its new collection of 2015 prom dresses, ... new prom outfits are guaranteed to contain the perfect ... specially designed for 2015. Anyone who wants to buy ... website before Jan. 26, 2015, the deadline of the ...
Breaking Medicine News(10 mins):Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:Don't Let Burns Mar Your Holidays 2Health News:Angelweddingdress 2015 Prom Dresses Online Now 2
... SAN DIEGO, Dec. 13 BioMed Realty Trust, Inc.,(NYSE: ... directors has declared a,fourth quarter 2007 dividend of $0.31 ... an annualized dividend of $1.24 per common share., ... declared a,dividend of $0.46094 per share of the company,s ...
... to persist with using creams, supplements and plastic surgery to ... new research says. , A study of 297 women ... more motivated to persist with special diets, vitamins, creams, Botox ... failed to make them look significantly younger. , The ...
... The HealthCentral,Network, Inc. ( http://www.HealthCentral.com ) has ... for its breast cancer site,MyBreastCancerNetwork.com, and its ... health industry innovation on the Web, the ... consumer disease-focused site.,MyBreastCancerNetwork.com won a Gold Award ...
... savings for,improving Medicare program; National Kidney Foundation, Renal ... submit letters to,Capitol Hill in favor of ESRD ... --,a coalition of patient advocates, dialysis professionals, care ... care for,individuals with chronic kidney disease -- and ...
... lead to new treatments for sleep disorders ... switch that activates the genetic mechanism regulating the body,s ... Irvine, researchers. , They added that the switch offers ... treat sleep disorders and related problems. , The study ...
... delivered today at a press conference hosted by ... agreement with Independent,Health, BUFFALO, N.Y., Dec. 12 ... Nielsen, M.D., AMA President-elect:, "The American Medical ... care, and initiatives that measure and compare physician,performance ...
Cached Medicine News:Health News:BioMed Realty Trust Declares Fourth Quarter 2007 Common Stock and Preferred Stock Dividends 2Health News:Women persist in plastic surgery treatments that are not working, research says 2Health News:The HealthCentral Network Wins eHealthcare Awards for Breast Cancer and Migraine Web Sites 2Health News:Kidney Patient Organizations, Kidney Community Come Out in Support of Medicare Secondary Payer (MSP) Extension 2Health News:Kidney Patient Organizations, Kidney Community Come Out in Support of Medicare Secondary Payer (MSP) Extension 3Health News:AMA Commends Independent Health for Joining Industry Shift on Physician Performance Measurement 2
... to optimize the accuracy and precision of ... is widely recognized by customers throughout the ... over the years and now covers a ... including filter tips, certified pure tips, stepper ...
... Finntips have been designed to optimize ... quality of our tip products is widely ... Finntip range has been extended over the ... of standard and special tips including filter ...
... plastic-wrapped racks of 96 tips, Sterilized Diamond- ... autoclave. Sterilized Diamond Tips are irradiated by ... delivered with a certificate of sterilization, specifying ... are certified free of detectable Rnase, Dnase, ...
... conveniently in plastic-wrapped racks of 96 tips, ... need to autoclave. Sterilized Diamond Tips are ... and are delivered with a certificate of ... Diamond Tips are certified free of detectable ...
Medicine Products: